News - Forest Laboratories


Current filters:

Forest Laboratories

Popular Filters

73 to 78 of 78 results

Forest Labs 1st-qtr 2011 profit more than doubles


US drugmaker Forest Laboratories (NYSE: FRX) reported profit of $258.1 million and earnings per share…

FinancialForest LaboratoriesPharmaceutical

Positive Ph III results for Forest Labs and Pierre Fabre’s levomilnacipran in major depressive disorder


US drugmaker Forest Laboratories (NYSE: FRX) and France’s third-largest pharma firm Pierre Fabre…

Forest LaboratorieslevomilnacipranNeurologicalPharmaceuticalPierre FabreResearch

Forest and Almirall see early filing of COPD drug aclidinium with US FDA; Appointment at Almirall


Spain’s largest pharma company Almirall (ALM. MC) and US marketing partner Forest Laboratories (NYSE:…

aclidiniumAlmirallEuropeForest LaboratoriesManagementNorth AmericaPharmaceuticalRegulationRespiratory and Pulmonary

Icahn seeks to put four new members on Forest Labs’ board


US drugmaker Forest Laboratories (NYSE: FRX) says that it has received notice from High River Limited…

Forest LaboratoriesManagementPharmaceutical

Forest Labs FY 4th-qtr beats forecasts; in-licenses antiarrhythmic


US drugmaker Forest Laboratories (NYSE: FRX) reported that, for its fiscal fourth quarter ended March…

azimilideCardio-vascularFinancialForest LaboratoriesLicensingPharmaceutical

73 to 78 of 78 results

Back to top